GlassScriptPhysician profile
Gillian Long
NPI 1790345726
$543.98
in general payments reported to CMS, 2019-2025
16 companies · $108 in 2025
The $108 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $282 · 2022: $40.54 · 2024: $113 · 2025: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $221.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $220.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $136.97 | 2021 | |
| Lilly USA, LLC | $63.65 | 2024-2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $62.65 | 2021-2025 | Wegovy, Rybelsus, Ozempic |
| Abbvie INC. | $35.15 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.76 | 2021 | |
| Exact Sciences Corporation | $28.18 | 2025 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $27.84 | 2024-2025 | Airsupra |
| Sanofi-Aventis U.S. LLC | $24.74 | 2021 | |
| Amarin Pharma, INC. | $23.77 | 2021 | |
| Almatica Pharma LLC | $20.00 | 2025 | Teriparatide, Loreev Xr |
| Dexcom, INC. | $18.92 | 2021 | |
| Novartis Pharmaceuticals Corporation | $16.16 | 2021 | |
| Amgen INC. | $15.54 | 2024 | Repatha, Otezla |
| Boston Scientific Corporation | $13.61 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $12.69 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $11.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gillian Long listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.